• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-淀粉样蛋白与阿尔茨海默病的发病基础。

Amyloid beta protein and the basis for Alzheimer's disease.

作者信息

Glenner G G

机构信息

University of California, San Diego, Department of Pathology, School of Medicine, La Jolla 92093.

出版信息

Prog Clin Biol Res. 1989;317:857-68.

PMID:2690126
Abstract

The amyloid fibril protein isolated from the cerebrovascular amyloid deposits seen in 92% of cases of Alzheimer's disease and 100% of cases of Down's syndrome over the age of 40 has been shown to have a previously unknown amino acid sequence. This protein has been designated beta protein (beta P) and the type amyloid fibrils, ACv beta. Polyclonal and monoclonal antibodies raised to a synthetic peptide comprising the first 10 amino acids of beta P localized both to cerebrovascular amyloid deposits as well as to the amyloid cores of all "senile" plaques. An amino acid sequence analysis based on that of the beta P has been reported indicating that the plaque amyloid fibril deposits are also composed of beta P. These deposits must cause severe disruption of neuronal fibers. Thus beta P in the form of amyloid deposits seems intrinsic to the destruction of neuronal competence and thus to the ensuing dementia of Alzheimer's disease. Since proteolysis converts the beta P precursor (Pre beta P) into amyloid fibrils, it is possible that 1) an abnormality in synthesis of the Pre beta P, perhaps during post-transitional events, or 2) an abnormality in proteolytic processing occurs to afford beta P deposits and the pathologic changes in Alzheimer's disease. Regardless of the processing abnormality, beta P represents a major component in the pathogenesis of Alzheimer's disease.

摘要

从脑血管淀粉样沉积物中分离出的淀粉样纤维蛋白,在92%的阿尔茨海默病病例和100% 40岁以上的唐氏综合征病例中可见,已被证明具有先前未知的氨基酸序列。这种蛋白质被命名为β蛋白(βP),淀粉样纤维类型为ACvβ。针对包含βP前10个氨基酸的合成肽产生的多克隆和单克隆抗体,既能定位到脑血管淀粉样沉积物,也能定位到所有“老年”斑的淀粉样核心。据报道,基于βP的氨基酸序列分析表明,斑淀粉样纤维沉积物也由βP组成。这些沉积物必定会严重破坏神经纤维。因此,淀粉样沉积物形式的βP似乎是神经元功能破坏以及随之而来的阿尔茨海默病痴呆症的内在因素。由于蛋白水解作用将βP前体(PreβP)转化为淀粉样纤维,有可能:1)PreβP合成异常,可能发生在翻译后事件期间;或者2)蛋白水解加工异常,从而导致βP沉积和阿尔茨海默病的病理变化。无论加工异常情况如何,βP都是阿尔茨海默病发病机制中的主要成分。

相似文献

1
Amyloid beta protein and the basis for Alzheimer's disease.β-淀粉样蛋白与阿尔茨海默病的发病基础。
Prog Clin Biol Res. 1989;317:857-68.
2
[The pathogenesis of Alzheimer's disease demonstrated by immunocytochemistry with anti-beta-protein antibody].用抗β蛋白抗体免疫细胞化学法证明的阿尔茨海默病发病机制
Yakubutsu Seishin Kodo. 1992 Jun;12(3):141-9.
3
A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.阿尔茨海默病和成年唐氏综合征患者大脑中β淀粉样蛋白免疫反应性斑块及相关病变的形态学与分布研究
Prog Clin Biol Res. 1989;317:313-23.
4
Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.阿尔茨海默病中淀粉样β蛋白在脑组织以外的组织中的沉积。
Nature. 1989 Sep 21;341(6239):226-30. doi: 10.1038/341226a0.
5
Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.阿尔茨海默病、唐氏综合征及非痴呆老年人的脑细胞外淀粉样前体蛋白沉积物
Prog Clin Biol Res. 1989;317:1001-5.
6
Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.从阿尔茨海默病和其他类型的脑淀粉样变性中分离和鉴定淀粉样蛋白P成分。
Lab Invest. 1988 Apr;58(4):454-8.
7
Beta-amyloid: Alzheimer's disease and brain beta-amyloidoses.β-淀粉样蛋白:阿尔茨海默病与脑β-淀粉样变性
Biochemistry (Mosc). 1999 Jul;64(7):752-7.
8
Immunogold labeling of cerebrovascular and neuritic plaque amyloid fibrils in Alzheimer's disease with an anti-beta protein monoclonal antibody.用抗β蛋白单克隆抗体对阿尔茨海默病脑血管和神经炎性斑块淀粉样原纤维进行免疫金标记。
Lab Invest. 1987 Oct;57(4):446-9.
9
Alpha 1-antichymotrypsin in brain aging and disease.脑衰老和疾病中的α1-抗糜蛋白酶
Prog Clin Biol Res. 1989;317:1037-48.
10
Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls.阿尔茨海默病淀粉样前体蛋白与淀粉样蛋白在脑血管壁中的共存。
Lab Invest. 1990 Jun;62(6):761-7.

引用本文的文献

1
The Framework for an Integrative Theory of Alzheimer's Disease.阿尔茨海默病综合理论框架
Curr Alzheimer Res. 2025;22(3):179-204. doi: 10.2174/0115672050381553250425062803.
2
Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications.阿尔茨海默病大脑中的脂质组破坏:检测、病理机制及治疗意义
Mol Neurodegener. 2025 Jan 27;20(1):11. doi: 10.1186/s13024-025-00803-6.
3
Towards the Integrative Theory of Alzheimer's Disease: Linking Molecular Mechanisms of Neurotoxicity, Beta-amyloid Biomarkers, and the Diagnosis.
迈向阿尔茨海默病综合理论:连接神经毒性的分子机制、β-淀粉样蛋白生物标志物和诊断。
Curr Alzheimer Res. 2023;20(6):440-452. doi: 10.2174/1567205020666230821141745.
4
Anti-amyloid therapies work for Alzheimer's disease.抗淀粉样蛋白疗法对阿尔茨海默病有效。
Brain Commun. 2023 Jul 17;5(4):fcad204. doi: 10.1093/braincomms/fcad204. eCollection 2023.
5
Therapeutic roles of plants for 15 hypothesised causal bases of Alzheimer's disease.植物对阿尔茨海默病15种假设病因的治疗作用。
Nat Prod Bioprospect. 2022 Aug 23;12(1):34. doi: 10.1007/s13659-022-00354-z.
6
Luteolin alleviates cognitive impairment in Alzheimer's disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation.木樨草素通过抑制内质网应激依赖性神经炎症减轻阿尔茨海默病小鼠模型的认知障碍。
Acta Pharmacol Sin. 2022 Apr;43(4):840-849. doi: 10.1038/s41401-021-00702-8. Epub 2021 Jul 15.
7
APP Function and Lipids: A Bidirectional Link.淀粉样前体蛋白(APP)功能与脂质:双向联系
Front Mol Neurosci. 2017 Mar 10;10:63. doi: 10.3389/fnmol.2017.00063. eCollection 2017.
8
Modulation of Amyloid β-Protein (Aβ) Assembly by Homologous C-Terminal Fragments as a Strategy for Inhibiting Aβ Toxicity.同源C末端片段对淀粉样β蛋白(Aβ)组装的调节作用:一种抑制Aβ毒性的策略
ACS Chem Neurosci. 2016 Jul 20;7(7):845-56. doi: 10.1021/acschemneuro.6b00154. Epub 2016 Jul 5.
9
Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.阿尔茨海默病:作为 MRI 治疗诊断试剂的磁性纳米粒子的病理生理学和应用。
ACS Chem Neurosci. 2013 Nov 20;4(11):1417-29. doi: 10.1021/cn4001582. Epub 2013 Sep 26.
10
The mitochondrial permeability transition in neurologic disease.神经疾病中的线粒体通透性转换
Neurochem Int. 2007 Jun;50(7-8):983-97. doi: 10.1016/j.neuint.2007.02.008. Epub 2007 Mar 4.